ROSEN, SKILLED INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation – ALVO

New York, New York–(Newsfile Corp. – January 18, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Alvotech (NASDAQ: ALVO) resulting from allegations that Alvotech may have issued materially misleading business information to the investing public. SO WHAT: If you purchased […]

ROSEN, THE FIRST FILING FIRM, Encourages Klarna Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KLAR

(NYSE:KLAR), NEW YORK, Jan. 18, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Klarna Group plc (NYSE: KLAR) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Klarna's September 2025 initial public offering (the “IPO”),

ROSEN, THE FIRST FILING FIRM, Encourages Klarna Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KLAR

ROSEN, THE FIRST FILING FIRM, Encourages Klarna Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KLAR GlobeNewswire January 18, 2026 NEW YORK, Jan. 18, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Klarna

Bronstein, Gewirtz & Grossman, LLC Is Investigating SelectQuote, Inc. (SLQT) And Encourages Investors to Connect

NEW YORK, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE:SLQT). Investors who purchased SelectQuote securities prior to September 9, 2020, and continue to hold to the present, are encouraged to obtain additional information

Pomerantz LLP Issues Important Reminder to Investors in F5, Inc. of Class Action – FFIV

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against F5, Inc. ("F5" or the "Company") (NASDAQ:FFIV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Pomerantz LLP Alerts Shareholders to Investor Suit Against Charming Medical Ltd. – MCTA

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Charming Medical Ltd. ("Charming" or the "Company") (NASDAQ:MCTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Pomerantz LLP Files Class Action Lawsuit Against SLM Corporation – SLM

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against SLM Corporation ("SLM" or the "Company") (NASDAQ:SLM) and certain officers.�� The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-18834, is

Bronstein, Gewirtz & Grossman, LLC Is Investigating Methode Electronics, Inc. (MEI) And Encourages Investors to Connect

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Methode Electronics, Inc. ("Methode Electronics" or "the Company") (NYSE:MEI). Investors who purchased Methode Electronics securities prior to December 2, 2021, and continue to hold to the present, are encouraged

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect

NEW YORK, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain additional

Pomerantz LLP Reminds Shareholders: Securities Lawsuit Has Been Filed Against Gauzy Ltd. – GAUZ

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Gauzy Ltd. ("Gauzy" or the "Company") (NASDAQ:GAUZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Scroll to Top